ATM-dependent DNA damage response constrains cell growth and drives clonal hematopoiesis in telomere biology disorders
Authors:
- Christopher M. SandeCSChristopher M. Sande
- Stone ChenSCStone Chen
- Dana V. MitchellDMDana V. Mitchell
- Ping LinPLPing Lin
- Diana M. AbrahamDADiana M. Abraham
- Talia GebhardTGTalia Gebhard
- Rujul J. DeolikarRDRujul J. Deolikar
- Colby FreemanCFColby Freeman
- Mary ZhouMZMary Zhou
- Sushant KumarSKSushant Kumar
- Michael BowmanMBMichael Bowman
Open Access
- 27 February 2025
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (8)
Abstract
Telomere biology disorders (TBDs) are genetic diseases caused by defective telomere maintenance. TBD patients often develop bone marrow failure and have an increased risk of myeloid neoplasms. To better understand the factors underlying hematopoietic outcomes in TBD, we comprehensively evaluated acquired genetic alterations in hematopoietic cells from 166 pediatric and adult TBD patients. Of these patients, 47.6% (28.8% of children, 56.1% of adults) had clonal hematopoiesis. Recurrent somatic alterations involved telomere maintenance genes (7.6%), spliceosome genes (10.4%, mainly U2AF1 p.S34), and chromosomal alterations (20.2%), including 1q gain (5.9%). Somatic variants affecting the DNA damage response (DDR) were identified in 21.5% of patients, including 20 presumed loss-of-function variants in ataxia-telangiectasia mutated ( ATM ). Using multimodal approaches, including single-cell sequencing, assays of ATM activation, telomere dysfunction-induced foci analysis, and cell-growth assays, we demonstrate telomere dysfunction–induced activation of the ATM-dependent DDR pathway with increased senescence and apoptosis in TBD patient cells. Pharmacologic ATM inhibition, modeling the effects of somatic ATM variants, selectively improved TBD cell fitness by allowing cells to bypass DDR-mediated senescence without detectably inducing chromosomal instability. Our results indicate that ATM-dependent DDR induced by telomere dysfunction is a key contributor to TBD pathogenesis and suggest dampening hyperactive ATM-dependent DDR as a potential therapeutic intervention.Keywords
Funding Information
- Team Telomere and the Penn Orphan Disease Center (N/A)
- Uplifting Athletes and Team Telomere (N/A)
- National Human Genome Research Institute (2T32HG009495-06)
- American Society of Hematology (N/A)
- American Society of Hematology (N/A)
- National Institute of Allergy and Infectious Diseases (AI 055413-19)
- National Heart, Lung, and Blood Institute (K01HL155231)
- National Heart, Lung, and Blood Institute (5R01HL131744)
- National Heart, Lung, and Blood Institute (5R01HL148821)
- Leukemia and Lymphoma Society (N/A)
- Edward P. Evans Foundation (N/A)
- Farmor Foundation (N/A)
This publication has 82 references indexed in Scilit:
- Meiotic Telomere Distribution and Sertoli Cell Nuclear Architecture Are Altered in Atm- andAtm-p53-Deficient MiceMolecular and Cellular Biology, 2000
- Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in miceNature, 2000
- A Sense of the EndScience, 2000
- From the Cover: Abnormal development of Purkinje cells and lymphocytes in Atm mutant miceProceedings of the National Academy of Sciences, 2000
- Atm Inactivation Results in Aberrant Telomere Clustering during Meiotic ProphaseMolecular and Cellular Biology, 1999
- Mammalian Telomeres End in a Large Duplex LoopCell, 1999
- p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate CarcinogenesisCell, 1999
- p53- and ATM-Dependent Apoptosis Induced by Telomeres Lacking TRF2Science, 1999
- Normal telomere maintenance in immortal ataxia telangiectasia cell linesMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1997
- Accelerated telomere shortening in ataxia telangiectasiaNature Genetics, 1996